 Antibodies
"Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
| Descriptor ID |
D000906
|
| MeSH Number(s) |
D12.776.124.486.485.114 D12.776.124.790.651.114 D12.776.377.715.548.114
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Antibodies".
- Antibodies
- Antibodies, Anti-Idiotypic
- Antibodies, Archaeal
- Antibodies, Bacterial
- Antibodies, Bispecific
- Antibodies, Blocking
- Antibodies, Catalytic
- Antibodies, Fungal
- Antibodies, Helminth
- Antibodies, Heterophile
- Antibodies, Immobilized
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antibodies, Neutralizing
- Antibodies, Phospho-Specific
- Antibodies, Protozoan
- Antibodies, Viral
- Antigen-Antibody Complex
- Antitoxins
- Autoantibodies
- Immune Sera
- Immunoconjugates
- Immunoglobulin Allotypes
- Immunoglobulin Isotypes
- Immunoglobulins, Intravenous
- Immunoglobulins, Thyroid-Stimulating
- Insulin Antibodies
- Isoantibodies
- Oligoclonal Bands
- Opsonin Proteins
- Plantibodies
- Precipitins
- Reagins
This graph shows the total number of publications written about "Antibodies" by people in this website by year, and whether "Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1981 | 2 | 1 | 3 | | 1982 | 1 | 0 | 1 | | 1983 | 1 | 2 | 3 | | 1984 | 0 | 4 | 4 | | 1985 | 1 | 2 | 3 | | 1986 | 2 | 3 | 5 | | 1987 | 2 | 2 | 4 | | 1988 | 2 | 2 | 4 | | 1989 | 1 | 2 | 3 | | 1990 | 3 | 4 | 7 | | 1991 | 1 | 2 | 3 | | 1992 | 2 | 3 | 5 | | 1993 | 5 | 3 | 8 | | 1994 | 5 | 7 | 12 | | 1995 | 1 | 9 | 10 | | 1996 | 2 | 4 | 6 | | 1997 | 0 | 8 | 8 | | 1998 | 1 | 5 | 6 | | 1999 | 0 | 4 | 4 | | 2000 | 1 | 8 | 9 | | 2001 | 1 | 8 | 9 | | 2002 | 1 | 11 | 12 | | 2003 | 1 | 7 | 8 | | 2004 | 4 | 16 | 20 | | 2005 | 8 | 10 | 18 | | 2006 | 4 | 5 | 9 | | 2007 | 2 | 5 | 7 | | 2008 | 2 | 10 | 12 | | 2009 | 4 | 7 | 11 | | 2010 | 5 | 4 | 9 | | 2011 | 3 | 1 | 4 | | 2012 | 3 | 6 | 9 | | 2013 | 4 | 9 | 13 | | 2014 | 3 | 13 | 16 | | 2015 | 9 | 6 | 15 | | 2016 | 8 | 3 | 11 | | 2017 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies" by people in Profiles.
-
Rimm DL, Han G, Taube JM, Yi ES, Bridge JA, Flieder DB, Homer R, West WW, Wu H, Roden AC, Fujimoto J, Yu H, Anders R, Kowalewski A, Rivard C, Rehman J, Batenchuk C, Burns V, Hirsch FR, Wistuba II. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA Oncol. 2017 Aug 01; 3(8):1051-1058.
-
Sukumar S, Wilson DC, Yu Y, Wong J, Naravula S, Ermakov G, Riener R, Bhagwat B, Necheva AS, Grein J, Churakova T, Mangadu R, Georgiev P, Manfra D, Pinheiro EM, Sriram V, Bailey WJ, Herzyk D, McClanahan TK, Willingham A, Beebe AM, Sadekova S. Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells. Cancer Res. 2017 Aug 15; 77(16):4378-4388.
-
Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017 Jun 05; 214(6):1737-1752.
-
Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, Storm TA, Schubert S, Hutter G, Narayanan C, Chu P, Raabe EH, Harsh G, Taylor MD, Monje M, Cho YJ, Majeti R, Volkmer JP, Fisher PG, Grant G, Steinberg GK, Vogel H, Edwards M, Weissman IL, Cheshier SH. Disrupting the CD47-SIRPa anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Sci Transl Med. 2017 Mar 15; 9(381).
-
Detweiler CS. A New Way to Beat Intestinal Pathogens. Trends Microbiol. 2017 03; 25(3):169-170.
-
Simpson K, Browning M. Antibodies That Work Again and Again and Again. Methods Mol Biol. 2017; 1554:41-59.
-
Brasino M, Cha JN. Real-time femtomolar detection of cancer biomarkers from photoconjugated antibody-phage constructs. Analyst. 2016 12 19; 142(1):91-97.
-
Alsuliman A, Muftuoglu M, Khoder A, Ahn YO, Basar R, Verneris MR, Muranski P, Barrett AJ, Liu E, Li L, Stringaris K, Armstrong-James D, Shaim H, Kondo K, Imahashi N, Andersson B, Marin D, Champlin RE, Shpall EJ, Rezvani K. A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML. Blood. 2017 02 09; 129(6):740-758.
-
Kelher MR, Banerjee A, Gamboni F, Anderson C, Silliman CC. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model. Transfusion. 2016 12; 56(12):3004-3011.
-
Chapuy CI, Aguad MD, Nicholson RT, AuBuchon JP, Cohn CS, Delaney M, Fung MK, Unger M, Doshi P, Murphy MF, Dumont LJ, Kaufman RM. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion. 2016 12; 56(12):2964-2972.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|